Cargando…

Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study

CONTEXT: Early detection of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSMF) transforming into malignancy can drastically improve the treatment outcomes and prognosis. Carcinoma development is an intricate complex mechanism and the multifactorial causation makes it more difficu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosavi, Suchitra Rajesh, Torkadi, Amruta Appasaheb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269289/
https://www.ncbi.nlm.nih.gov/pubmed/32508447
http://dx.doi.org/10.4103/jomfp.JOMFP_317_19
_version_ 1783541751510728704
author Gosavi, Suchitra Rajesh
Torkadi, Amruta Appasaheb
author_facet Gosavi, Suchitra Rajesh
Torkadi, Amruta Appasaheb
author_sort Gosavi, Suchitra Rajesh
collection PubMed
description CONTEXT: Early detection of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSMF) transforming into malignancy can drastically improve the treatment outcomes and prognosis. Carcinoma development is an intricate complex mechanism and the multifactorial causation makes it more difficult to find specific prognostic and therapeutic biomarkers. Thus, the development of newer diagnostic and predictive approaches that are less invasive, economical and amenable to repeated sampling is imperative. Serum C-reactive protein (CRP) serves a useful marker for prognosis and monitoring of oral potentially malignant disorders (OPMDs) including OSMF as well as OSCC. Secreted by hepatocyte as an acute inflammatory marker, various studies have shown association between serum CRP and presence of OPMDs, as well as with presence and prognosis of OSCC. AIMS: The aim of this study was to measure and compare serum CRP levels in patients with OSMF and OSCC as compared to healthy individuals and to establish baseline data for serum CRP levels in patients with OSMF and OSCC. SETTINGS AND DESIGN: Cross-sectional observational prospective study. MATERIALS AND METHODOLOGY: The study includes 150 individuals, with 50 healthy, 50 OSMF and 50 OSCC individuals. Spinreact CRP-turbilatex Kit (SPINREACT) and Prietest-EXP semi-automatic biochemical analyzer were used for quantitative determination of serum CRP. STATISTICAL ANALYSIS USED: Data were analyzed by SPSS 16(©) (Statistical Package for the Social Sciences) software. RESULTS: The mean value of serum CRP in Group I was 2.20 mg/L with standard deviation of 1.74; in Group II, it was 5.40 mg/L with standard deviation of 4.79 mg/L and in Group III, it was 12.17 mg/L with standard deviation of 11.38. CONCLUSIONS: Serum CRP levels in patients with OSMF were raised, but not statistically significant as compared to the control group. Values of serum CRP were significantly higher in patients with OSCC as compared to the control group, and it was statistically significant; these values also showed positive association with primary tumor size.
format Online
Article
Text
id pubmed-7269289
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-72692892020-06-05 Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study Gosavi, Suchitra Rajesh Torkadi, Amruta Appasaheb J Oral Maxillofac Pathol Original Article CONTEXT: Early detection of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSMF) transforming into malignancy can drastically improve the treatment outcomes and prognosis. Carcinoma development is an intricate complex mechanism and the multifactorial causation makes it more difficult to find specific prognostic and therapeutic biomarkers. Thus, the development of newer diagnostic and predictive approaches that are less invasive, economical and amenable to repeated sampling is imperative. Serum C-reactive protein (CRP) serves a useful marker for prognosis and monitoring of oral potentially malignant disorders (OPMDs) including OSMF as well as OSCC. Secreted by hepatocyte as an acute inflammatory marker, various studies have shown association between serum CRP and presence of OPMDs, as well as with presence and prognosis of OSCC. AIMS: The aim of this study was to measure and compare serum CRP levels in patients with OSMF and OSCC as compared to healthy individuals and to establish baseline data for serum CRP levels in patients with OSMF and OSCC. SETTINGS AND DESIGN: Cross-sectional observational prospective study. MATERIALS AND METHODOLOGY: The study includes 150 individuals, with 50 healthy, 50 OSMF and 50 OSCC individuals. Spinreact CRP-turbilatex Kit (SPINREACT) and Prietest-EXP semi-automatic biochemical analyzer were used for quantitative determination of serum CRP. STATISTICAL ANALYSIS USED: Data were analyzed by SPSS 16(©) (Statistical Package for the Social Sciences) software. RESULTS: The mean value of serum CRP in Group I was 2.20 mg/L with standard deviation of 1.74; in Group II, it was 5.40 mg/L with standard deviation of 4.79 mg/L and in Group III, it was 12.17 mg/L with standard deviation of 11.38. CONCLUSIONS: Serum CRP levels in patients with OSMF were raised, but not statistically significant as compared to the control group. Values of serum CRP were significantly higher in patients with OSCC as compared to the control group, and it was statistically significant; these values also showed positive association with primary tumor size. Wolters Kluwer - Medknow 2020 2020-05-08 /pmc/articles/PMC7269289/ /pubmed/32508447 http://dx.doi.org/10.4103/jomfp.JOMFP_317_19 Text en Copyright: © 2020 Journal of Oral and Maxillofacial Pathology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gosavi, Suchitra Rajesh
Torkadi, Amruta Appasaheb
Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title_full Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title_fullStr Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title_full_unstemmed Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title_short Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study
title_sort serum c-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269289/
https://www.ncbi.nlm.nih.gov/pubmed/32508447
http://dx.doi.org/10.4103/jomfp.JOMFP_317_19
work_keys_str_mv AT gosavisuchitrarajesh serumcreactiveproteininoralsubmucousfibrosisandoralsquamouscellcarcinomaacrosssectionalstudy
AT torkadiamrutaappasaheb serumcreactiveproteininoralsubmucousfibrosisandoralsquamouscellcarcinomaacrosssectionalstudy